AstraZeneca
The Director, Global Scientific Communications, Hematology at Alexion, AstraZeneca Rare Disease will lead the global scientific communications strategy, publication planning, and medical education for a high-impact Hematology portfolio. This senior role chairs the Global Publication Team, partners with cross‑functional stakeholders, and ensures the accurate and impactful communication of scientific data to healthcare professionals and the broader medical community.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
33% above the average for this role
Principal Scientific Communications Specialist
Med Communications
Director, Scientific Communications
kaileratherapeutics
Scientific Communications Contractor
Med Communications
Global Scientific Communications Lead- Rare Diseases
sanofi us
Sr. Director, Scientific Communications & Medical Communications
Mineralys Therapeutics
Associate Director, Scientific Communications Lead, Hematology, Global Medical Affairs Oncology
Takeda Pharmaceutical Company Limited